262 related articles for article (PubMed ID: 37340205)
1. Flavonoid Myricetin as Potent Anticancer Agent: A Possibility towards Development of Potential Anticancer Nutraceuticals.
Trivedi A; Hasan A; Ahmad R; Siddiqui S; Srivastava A; Misra A; Mir SS
Chin J Integr Med; 2024 Jan; 30(1):75-84. PubMed ID: 37340205
[TBL] [Abstract][Full Text] [Related]
2. Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications.
Taheri Y; Suleria HAR; Martins N; Sytar O; Beyatli A; Yeskaliyeva B; Seitimova G; Salehi B; Semwal P; Painuli S; Kumar A; Azzini E; Martorell M; Setzer WN; Maroyi A; Sharifi-Rad J
BMC Complement Med Ther; 2020 Aug; 20(1):241. PubMed ID: 32738903
[TBL] [Abstract][Full Text] [Related]
3. SAR and QSAR of the antioxidant activity of flavonoids.
Amić D; Davidović-Amić D; Beslo D; Rastija V; Lucić B; Trinajstić N
Curr Med Chem; 2007; 14(7):827-45. PubMed ID: 17346166
[TBL] [Abstract][Full Text] [Related]
4. Myricetin: a potential plant-derived anticancer bioactive compound-an updated overview.
Kumar S; Swamy N; Tuli HS; Rani S; Garg A; Mishra D; Abdulabbas HS; Sandhu SS
Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2179-2196. PubMed ID: 37083713
[TBL] [Abstract][Full Text] [Related]
5. Myricetin: A Significant Emphasis on Its Anticancer Potential via the Modulation of Inflammation and Signal Transduction Pathways.
Rahmani AH; Almatroudi A; Allemailem KS; Alwanian WM; Alharbi BF; Alrumaihi F; Khan AA; Almatroodi SA
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298616
[TBL] [Abstract][Full Text] [Related]
6. Myricetin: A Dietary Molecule with Diverse Biological Activities.
Semwal DK; Semwal RB; Combrinck S; Viljoen A
Nutrients; 2016 Feb; 8(2):90. PubMed ID: 26891321
[TBL] [Abstract][Full Text] [Related]
7. Insight into Potential Anticancer Activity of Algal Flavonoids: Current Status and Challenges.
Ferdous UT; Balia Yusof ZN
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833937
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory and anti-allergic potential of dietary flavonoids: A review.
Rakha A; Umar N; Rabail R; Butt MS; Kieliszek M; Hassoun A; Aadil RM
Biomed Pharmacother; 2022 Dec; 156():113945. PubMed ID: 36411631
[TBL] [Abstract][Full Text] [Related]
9. A Switch between Antioxidant and Prooxidant Properties of the Phenolic Compounds Myricetin, Morin, 3',4'-Dihydroxyflavone, Taxifolin and 4-Hydroxy-Coumarin in the Presence of Copper(II) Ions: A Spectroscopic, Absorption Titration and DNA Damage Study.
Jomová K; Hudecova L; Lauro P; Simunkova M; Alwasel SH; Alhazza IM; Valko M
Molecules; 2019 Nov; 24(23):. PubMed ID: 31783535
[TBL] [Abstract][Full Text] [Related]
10. Myricetin exerts anti-proliferative, anti-invasive, and pro-apoptotic effects on esophageal carcinoma EC9706 and KYSE30 cells via RSK2.
Zang W; Wang T; Wang Y; Li M; Xuan X; Ma Y; Du Y; Liu K; Dong Z; Zhao G
Tumour Biol; 2014 Dec; 35(12):12583-92. PubMed ID: 25192723
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor effects and associated molecular mechanisms of myricetin.
Jiang M; Zhu M; Wang L; Yu S
Biomed Pharmacother; 2019 Dec; 120():109506. PubMed ID: 31586904
[TBL] [Abstract][Full Text] [Related]
12. A Review on Pharmacological and Analytical Aspects of Naringenin.
Patel K; Singh GK; Patel DK
Chin J Integr Med; 2018 Jul; 24(7):551-560. PubMed ID: 25501296
[TBL] [Abstract][Full Text] [Related]
13. The antitumor activities of flavonoids.
Kandaswami C; Lee LT; Lee PP; Hwang JJ; Ke FC; Huang YT; Lee MT
In Vivo; 2005; 19(5):895-909. PubMed ID: 16097445
[TBL] [Abstract][Full Text] [Related]
14. An Overview of Dietary Flavonoids as a Nutraceutical Nanoformulation Approach to Life-threatening Diseases.
Singh S; Ahuja A; Sharma H; Maheshwari P
Curr Pharm Biotechnol; 2023; 24(14):1740-1773. PubMed ID: 36918792
[TBL] [Abstract][Full Text] [Related]
15. Flavonoid-Based Cancer Therapy: An Updated Review.
Hosseinzadeh E; Hassanzadeh A; Marofi F; Alivand MR; Solali S
Anticancer Agents Med Chem; 2020; 20(12):1398-1414. PubMed ID: 32324520
[TBL] [Abstract][Full Text] [Related]
16. Flavonoids as anticancer agents: structure-activity relationship study.
López-Lázaro M
Curr Med Chem Anticancer Agents; 2002 Nov; 2(6):691-714. PubMed ID: 12678721
[TBL] [Abstract][Full Text] [Related]
17. Flavonoid-metal ion Complexes as Potent Anticancer Metallodrugs: A Comprehensive Review.
Zangade SB; Dhulshette BS; Patil PB
Mini Rev Med Chem; 2024; 24(10):1046-1060. PubMed ID: 37867263
[TBL] [Abstract][Full Text] [Related]
18. Current Pharmacological Trends on Myricetin.
Gupta G; Siddiqui MA; Khan MM; Ajmal M; Ahsan R; Rahaman MA; Ahmad MA; Arshad M; Khushtar M
Drug Res (Stuttg); 2020 Oct; 70(10):448-454. PubMed ID: 32877951
[TBL] [Abstract][Full Text] [Related]
19. Flavonoids as Anticancer Agents.
Kopustinskiene DM; Jakstas V; Savickas A; Bernatoniene J
Nutrients; 2020 Feb; 12(2):. PubMed ID: 32059369
[TBL] [Abstract][Full Text] [Related]
20. Chemistry and biological activities of flavonoids: an overview.
Kumar S; Pandey AK
ScientificWorldJournal; 2013; 2013():162750. PubMed ID: 24470791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
